Our Latest News - BUHLMANN

BUHLMANN News

CALEX® Cap

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. CALEX® Cap Stool Preparation Device- for fecal Calprotectin & fecal Pancreatic Elastase The BÜHLMANN CALEX® Cap is designed to provide convenient and safe stool extraction of multiple analytes. The optimized dilution of stool sample yields maximum extraction efficiency and analyte
Continue Reading

Four Years of Experience Using IBDoc

Benefits for Patients and Healthcare Staff of Routine IBDoc® Use Kathleen Sugrue, Advanced Nurse Practitioner at Mercy University Hospital, Cork (Article courtesy of BÜHLMANN’s UK distributor, Alpha Laboratories.) Highlight from this Perspective Article “Since introducing IBDoc® we get less calls on the helpline because patients can check themselves if they are concerned they are flaring.” “Patients
Continue Reading

Patient’s Perspective- One Year using IBDoc

Read a recent article written from the perspective of a long term Crohn's sufferer who shares his experience of managing the disease with the help of calprotectin self-testing. Article courtesy of BÜHLMANN’s UK distributor, Alpha Laboratories. Highlight from this Perspective Article “It has reduced the “waiting time” for results down to hours instead of days or
Continue Reading

Labsense News Summer 2019 Edition


Continue Reading

BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® turbo Automated Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, June 26, 2019: BÜHLMANN Laboratories AG, is proud to announce it received United States Food and Drug
Continue Reading

Head-to-head comparison of three stool calprotectin tests for home use

IBDoc® Citation: Haisma et al. Head-to-head comparison of three stool calprotectin tests for home use.  Plos ONE. https://doi.org/10.1371/journal.pone.0214751  April 18, 2019 Highlights from this Publication “ …We observed that 119 of 125 IBDoc readings ≥ 500 μg/g were concordant with fCAL results (95%), compared to 35% and 49% for the QuantOnCal—IDK-Calprotectin and CalproSmart—Calprotectin-ALP pairs.…” “The CalproSmart
Continue Reading

LabSense News Spring 2019 Edition

Continue Reading

Calprotectin in the Updated ACG Ulcerative Colitis Guidelines

Microscope photo of a human large intestine section with inflammation (Colitis). What is Ulcerative colitis? Ulcerative colitis (UC) is a chronic disease affecting the large intestine, in which the lining of the colon becomes inflamed and develops tiny open sores, or ulcers. This condition is the result of the immune system's overactive response.1 This is
Continue Reading

Check Us Out at AMLI 2019

We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications.  Anti-MAG Autoantibodies ELISA  US: Research Use Only.  Not for use in diagnostic procedures. Canada: Health Canada License: 89118 This assay is intended for the quantitative determination of human IgM-auto-antibodies directed
Continue Reading

Visit BUHLMANN at AACC 2019

 Assays Offerings: We offer a selection of unique, high-quality assays for Cellular Allergy testing such as the BÜHLMANN Flow CAST® product group  and numerous Allergens for Basophil Activation Testing and Neuroimmunology testing such as the BÜHLMANN GanglioCombi® products; the only screening ELISAs for anti-Ganglioside testing and Anti-MAG Autoantibodies ELISA. Other areas of BÜHLMANN’s focus include specialized niche products for Clinical Chemistry (ACE, GHB, etc.) as well
Continue Reading